We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong Holds Campaign for Children with Spinal Muscular Atrophy

By LabMedica International staff writers
Posted on 01 Sep 2022
Print article
Image: A day with SMA children (Photo courtesy of Tianlong)
Image: A day with SMA children (Photo courtesy of Tianlong)

Spinal muscular atrophy (SMA) is an inherited disease that affects the nerves and muscles, causing them to become increasingly weak. SMA affects mostly infants and children and ranks as the foremost fatal genetic disease for infants but can also develop in adults. Tianlong Science and Technology (Shaanxi, China), a leading manufacturer of molecular diagnostic products with a strong focus on social responsibility, recently held a campaign to care for children with SMA.

Tianlong offers PCR reagents covering 200 kinds of disease detection, including SMA. In addition to PCR reagents, Tianlong provides an integrated PCR lab solution from nucleic acid extractors and PCR systems to compatible reagents. Tianlong helped over 80 countries to build their healthcare systems during the COVID-19 pandemic, and the company’s nucleic acid extractors and PCR systems have been at the forefront in the fight against COVID-19. Based on the PCR melting curve method, Tianlong's Human Survival Motor Neuron 1 (SMN1) Gene Detection Kit is suitable for the auxiliary diagnosis of SMN1 patients and screening of SMN1 gene carriers.

Early detection of SMA can help with early diagnosis and treatment of the disease. In May 2022, Tianlong, in association with the SMA Care Center (a non-profit organization for SMA) in China and The Second Affiliated Hospital of Xi'an Jiaotong University, held a campaign aimed to create awareness about SMA and its early detection. During the campaign, Tianlong invited several families in China to join them in accompanying children with SMA for a day. Tianlong also hosted a lecture on SMA treatment and answered concerns of parents of children with SMA. Going forward, Tianlong will continue to work towards creating further awareness about the rare disease among people and identify more SMA children and their families. The company plans to use its advanced technologies for developing additional solutions to better care for SMA children globally.

 

 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.